Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
LONDON (AP) — The European Medicines Agency has recommended that the world's first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa.
The agency on Friday described licensing the vaccine as "an important step toward relieving the burden of this deadly disease." The Ebola vaccine was originally developed in Canada and is now marketed by Merck as Ervebo. More than 270,000 people in Africa have received it as officials try to stop Congo's ongoing outbreak.
A second vaccine made by Johnson & Johnson, which is not yet licensed, will soon be used in parts of Congo where Ebola is not actively spreading.
Also Friday, the World Health Organization is convening a meeting to consider whether the epidemic in Congo should still be designated a global emergency.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.